Zahra Ghasemi: How a Strategic Plasma Model Transformed Hemophilia Care
Zahra Ghasemi, Pharmacoeconomist, Member of Health Technology Assessment international and Cochrane, shared a post on LinkedIn about a recent article she and her colleagues co-authored, published in Iranian Journal of Blood and Cancer, adding:
”On 17th April, this World Hemophilia Day, we celebrate a triumph of science: in the early 1900s, a child born with hemophilia faced a life expectancy of just 13 years.
Today, that gift of life has reached 77 years.
This 64-year gain is the true ‘yield’ of professional and scientific dedication.
Having invested 6 years in the plasma-derived medicinal products industry, I am particularly proud to highlight the efficiency of Iran’s national plasma contract fractionation model, which has been recognized for many years by the World Health Organization as a role model for countries seeking to improve access to essential medicines.
In our published study in 2024, we analyzed how this strategic framework, bolstered by an 18.9% annual growth in plasma collection as the raw material for the manufacturing of vital medicines, has transformed care for hemophilia patients.
This resilient infrastructure now supports 5,500 patients with Factor VIII deficiency and 1,200 patients with Factor IX deficiency by covering 100% of needs through domestic production of our own ‘liquid gold,’ local Iranian plasma.
While the science is found in fractionation yields and HEOR modeling, the heart of this industry lies in the altruism of donors who have helped extend life expectancy from just 13 years to 77 years, ensuring that every patient has the chance to enjoy an extended lifespan.”
Title: Plasma Production in Iran: Streaming Towards Plasma Self-sufficiency
Author: Zahra Ghasemi, Hassan Abolghasemi,Fatemeh Babaei, Abdol Majid Cheraghali, Nazila Yousefi
Stay updated with Hemostasis Today.
-
May 13, 2026, 17:38Rohit Sankar J. Snscphysio: Recognizing the Clot Before It Becomes Life-Threatening
-
May 13, 2026, 16:41Seema Dawood: When Elevated Platelets Signal a Myeloproliferative Neoplasm
-
May 13, 2026, 16:38Kari Tikkinen: Defining Thromboprophylaxis in MIBC Neoadjuvant Care
-
May 13, 2026, 16:28Nadia Tarhini: Evaluating the Risk of Recurrent Thrombosis in Children with ALL
-
May 13, 2026, 16:01Sifat Jubaira: When Low MCV Meets High Platelets
-
May 13, 2026, 15:58Aktham El-rekaby: Immunothrombosis in Acute Ischaemic Stroke
-
May 13, 2026, 15:49Alison Dougall: Oral Health and Cardiovascular Risk in Bleeding Disorders
-
May 13, 2026, 15:38International Journal of Stroke: Oral Anticoagulants and DOAC–Antiplatelet Therapy Are Associated with Increased Major Bleeding Risk
-
May 13, 2026, 15:19Papa Heme։ Causes of Isolated Prolonged aPTT Without Bleeding